These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 9076814)
1. Follow-up of children with respiratory syncytial virus bronchiolitis in 1986 and 1987: potential effect of ribavirin on long term pulmonary function. The Bronchiolitis Study Group. Krilov LR; Mandel FS; Barone SR; Fagin JC Pediatr Infect Dis J; 1997 Mar; 16(3):273-6. PubMed ID: 9076814 [TBL] [Abstract][Full Text] [Related]
2. Prospective follow-up and pulmonary functions from a placebo-controlled randomized trial of ribavirin therapy in respiratory syncytial virus bronchiolitis. Ribavirin Study Group. Rodriguez WJ; Arrobio J; Fink R; Kim HW; Milburn C Arch Pediatr Adolesc Med; 1999 May; 153(5):469-74. PubMed ID: 10323626 [TBL] [Abstract][Full Text] [Related]
3. Does ribavirin impact on the hospital course of children with respiratory syncytial virus (RSV) infection? An analysis using the pediatric investigators collaborative network on infections in Canada (PICNIC) RSV database. Law BJ; Wang EE; MacDonald N; McDonald J; Dobson S; Boucher F; Langley J; Robinson J; Mitchell I; Stephens D Pediatrics; 1997 Mar; 99(3):E7. PubMed ID: 9099772 [TBL] [Abstract][Full Text] [Related]
4. Reduced long-term respiratory morbidity after treatment of respiratory syncytial virus bronchiolitis with ribavirin in previously healthy infants: a preliminary report. Edell D; Bruce E; Hale K; Edell D; Khoshoo V Pediatr Pulmonol; 1998 Mar; 25(3):154-8. PubMed ID: 9556006 [TBL] [Abstract][Full Text] [Related]
5. Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group. Rodriguez WJ; Gruber WC; Welliver RC; Groothuis JR; Simoes EA; Meissner HC; Hemming VG; Hall CB; Lepow ML; Rosas AJ; Robertsen C; Kramer AA Pediatrics; 1997 Mar; 99(3):454-61. PubMed ID: 9041304 [TBL] [Abstract][Full Text] [Related]
6. Ribavirin in ventilated respiratory syncytial virus bronchiolitis. A randomized, placebo-controlled trial. Guerguerian AM; Gauthier M; Lebel MH; Farrell CA; Lacroix J Am J Respir Crit Care Med; 1999 Sep; 160(3):829-34. PubMed ID: 10471604 [TBL] [Abstract][Full Text] [Related]
7. [Ribavirin in the treatment of bronchiolitis caused by syncytial respiratory virus]. Sánchez-Solís de Querol M; Castillo-Ochando F; Díaz-Torres M; Sayed-Sancho N; Sánchez-Flores F; Pajarón de Ahumada M An Esp Pediatr; 1997 Jul; 47(1):14-6. PubMed ID: 9290254 [TBL] [Abstract][Full Text] [Related]
8. Ribavirin for respiratory syncytial virus bronchiolitis reduced the risk of asthma and allergen sensitization. Chen CH; Lin YT; Yang YH; Wang LC; Lee JH; Kao CL; Chiang BL Pediatr Allergy Immunol; 2008 Mar; 19(2):166-72. PubMed ID: 18257904 [TBL] [Abstract][Full Text] [Related]
9. Ribavirin effect on pulmonary function in young infants with respiratory syncytial virus bronchiolitis. Janai HK; Stutman HR; Zaleska M; Rub B; Eyzaguirre M; Marks MI; Nussbaum E Pediatr Infect Dis J; 1993 Mar; 12(3):214-8. PubMed ID: 8451098 [TBL] [Abstract][Full Text] [Related]
10. A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients. Liu V; Dhillon GS; Weill D Transpl Infect Dis; 2010 Feb; 12(1):38-44. PubMed ID: 19761558 [TBL] [Abstract][Full Text] [Related]
11. Long term follow-up of children hospitalized with respiratory syncytial virus lower respiratory tract infection and randomly treated with ribavirin or placebo. Long CE; Voter KZ; Barker WH; Hall CB Pediatr Infect Dis J; 1997 Nov; 16(11):1023-8. PubMed ID: 9384333 [TBL] [Abstract][Full Text] [Related]
12. Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation. Glanville AR; Scott AI; Morton JM; Aboyoun CL; Plit ML; Carter IW; Malouf MA J Heart Lung Transplant; 2005 Dec; 24(12):2114-9. PubMed ID: 16364859 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection. Pelaez A; Lyon GM; Force SD; Ramirez AM; Neujahr DC; Foster M; Naik PM; Gal AA; Mitchell PO; Lawrence EC J Heart Lung Transplant; 2009 Jan; 28(1):67-71. PubMed ID: 19134533 [TBL] [Abstract][Full Text] [Related]
14. Driscoll Children's Hospital respiratory syncytial virus database: risk factors, treatment and hospital course in 3308 infants and young children, 1991 to 2002. Purcell K; Fergie J Pediatr Infect Dis J; 2004 May; 23(5):418-23. PubMed ID: 15131464 [TBL] [Abstract][Full Text] [Related]
15. Early ribavarin treatment of bronchiolitis: effect on long-term respiratory morbidity. Edell D; Khoshoo V; Ross G; Salter K Chest; 2002 Sep; 122(3):935-9. PubMed ID: 12226035 [TBL] [Abstract][Full Text] [Related]
16. Corticosteroid use as adjunct therapy for respiratory syncytial virus infection in adult allogeneic stem cell transplant recipients. Damlaj M; Bartoo G; Cartin-Ceba R; Gijima D; Alkhateeb HB; Merten J; Hashmi S; Litzow M; Gastineau D; Hogan W; Patnaik MM Transpl Infect Dis; 2016 Apr; 18(2):216-26. PubMed ID: 26909896 [TBL] [Abstract][Full Text] [Related]
17. Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage. Romero JR Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S46-54. PubMed ID: 12671452 [TBL] [Abstract][Full Text] [Related]
18. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children. Ventre K; Randolph A Cochrane Database Syst Rev; 2004 Oct; (4):CD000181. PubMed ID: 15494991 [TBL] [Abstract][Full Text] [Related]